Home > Insider Trading > Filing (0001203311-22-000052)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seagen Inc.	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1361966	B Vaughn Himes	21823 30Th Drive Se Bothell WA 98021	Chief Technical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-08-15	12,014	$0.00	72,294	No	4	A	Direct
Common Stock	Disposition	2022-08-16	658	$170.22	71,636	No	4	S	Direct
Common Stock	Disposition	2022-08-16	869	$170.22	70,767	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	119,471	Indirect	by Trust

Footnotes

These shares represent restricted stock units and will be settled in common stock upon vesting.
Shares shall vest at a rate of 25% on each anniversary of August 15, 2022 until all shares are fully vested at the end of four years.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 82 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 29, 2022.
Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.